Extrapolation and dosing recommendations for raxibacumab in children from birth to age <18 years-Reference-Cited by-同舟云学术

Extrapolation and dosing recommendations for raxibacumab in children from birth to age <18 years

Published:2021-07-13 Issue:12 Volume:87 Page:4709-4717
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Oosterholt Sean P.¹^ORCID,Della Pasqua Oscar¹²^ORCID

Affiliation:

1. Clinical Pharmacology & Therapeutics Group University College London UK

2. Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline Brentford UK

Funder

GlaxoSmithKline foundation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14893

Reference31 articles.

1. Code of Federal Regulations.Approval of new drugs when human efficacy studies are not ethical or feasible. Title 21 Food and Drug Administration 2002. Available at:https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=314&showFR=1&subpartNode=21:5.0.1.1.4.9. Last accessed on May 11 2020.

2. Code of Federal Regulations.Approval of biological products when human efficacy studies are not ethical or feasible. Title 21 Food and Drug Administration 2002. Available at:https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=601&showFR=1&subpartNode=21:7.0.1.1.2.8. Last accessed on May 11 2020.

3. Food and Drug Administration.CDER DRUG AND BIOLOGIC ANIMAL RULE APPROVALS.2018. Available at:https://www.fda.gov/media/107839/download. Last accessed on May 11 2020.

4. A Phase 1 Study of PAmAb, a Fully Human Monoclonal Antibody against Bacillus anthracis Protective Antigen, in Healthy Volunteers

5. What is the right dose for children?